share_log

Moderna | 4: Statement of changes in beneficial ownership of securities-Director AFEYAN NOUBAR

Moderna | 4: Statement of changes in beneficial ownership of securities-Director AFEYAN NOUBAR

Moderna | 4:持股变动声明-董事 AFEYAN NOUBAR
美股sec公告 ·  07/12 19:02
Moomoo AI 已提取核心信息
On July 10, 2024, Noubar Afeyan, associated with Moderna, Inc. [MRNA], executed a series of open market sales transactions of the company's common stock. Afeyan disposed of a total of 15,000 shares at prices ranging from $116.01 to $119.95, resulting in a total market value of approximately $1.76 million. Following these transactions, Afeyan directly holds 2,269,015 shares of Moderna. Additionally, indirect holdings through various entities associated with Flagship Pioneering, Inc. amount to 4,632,149 shares, with the largest portion held by Flagship Ventures Fund IV, L.P. at 3,880,328 shares.
On July 10, 2024, Noubar Afeyan, associated with Moderna, Inc. [MRNA], executed a series of open market sales transactions of the company's common stock. Afeyan disposed of a total of 15,000 shares at prices ranging from $116.01 to $119.95, resulting in a total market value of approximately $1.76 million. Following these transactions, Afeyan directly holds 2,269,015 shares of Moderna. Additionally, indirect holdings through various entities associated with Flagship Pioneering, Inc. amount to 4,632,149 shares, with the largest portion held by Flagship Ventures Fund IV, L.P. at 3,880,328 shares.
2024年7月10日,与Moderna,Inc. [MRNA]相关的Noubar Afeyan执行了一系列公司普通股的公开市场销售交易。Afeyan以116.01美元至119.95美元不等的价格销售了一共15,000股,从而产生了约176万美元的总市值。完成这些交易后,Afeyan直接持有Moderna的2,269,015股。此外,通过与Flagship Pioneering,Inc.相关的各种实体的间接持股为4,632,149股,其中Flagship Ventures Fund IV,L.P.所持有的股份最多,为3,880,328股。
2024年7月10日,与Moderna,Inc. [MRNA]相关的Noubar Afeyan执行了一系列公司普通股的公开市场销售交易。Afeyan以116.01美元至119.95美元不等的价格销售了一共15,000股,从而产生了约176万美元的总市值。完成这些交易后,Afeyan直接持有Moderna的2,269,015股。此外,通过与Flagship Pioneering,Inc.相关的各种实体的间接持股为4,632,149股,其中Flagship Ventures Fund IV,L.P.所持有的股份最多,为3,880,328股。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息